col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Association for the Advancement of Science (AAAS): Science Translational Medicine
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―27 Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models Neeltje van Doremalen, Jyothi N. Purushotham, Jonathan E. Schulz, Myndi G. Holbrook, Trenton Bushmaker, Aaron Carmody, et al. (+15)
2 [GO] 2021―Jul―27 Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates Joseph R. Francica, Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore, et al. (+54)
3 [GO] 2021―Jul―20 A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters Yangtao Wu, Xiaofen Huang, Lunzhi Yuan, Shaojuan Wang, Yali Zhang, Hualong Xiong, et al. (+30)
4 [GO] 2021―Jul―13 A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma Craig Fenwick, Priscilla Turelli, Céline Pellaton, Alex Farina, Jérémy Campos, Charlène Raclot, et al. (+8)
5 [GO] 2021―Jul―07 Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance Scott P. Layne, Jeffery K. Taubenberger
6 [GO] 2021―Jun―22 Undiagnosed SARS-CoV-2 Seropositivity During the First Six Months of the COVID-19 Pandemic in the United States Heather Kalish, Carleen Klumpp-Thomas, Sally Hunsberger, Holly Ann Baus, Michael P Fay, Nalyn Siripong, et al. (+47)
7 [GO] 2021―Jun―22 Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England Edward S. Knock, Lilith K. Whittles, John A. Lees, Pablo N. Perez-Guzman, Robert Verity, Richard G. FitzJohn, et al. (+25)
8 [GO] 2021―Jun―15 Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19 Mercedes Prudencio, Young Erben, Christopher P. Marquez, Karen R. Jansen-West, Camila Franco-Mesa, Michael G. Heckman, et al. (+15)
9 [GO] 2021―Jun―08 Plasma from patients with bacterial sepsis or severe COVID-19 induces production of suppressive myeloid cells from human hematopoietic progenitor cells in vitro Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, et al. (+12)
10 [GO] 2021―Jun―08 Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, Katharine H.D. Crawford, Tyler N. Starr, Keara D. Malone, et al. (+2)
11 [GO] 2021―Jun―02 First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes Jenna J. Guthmiller, Julianna Han, Lei Li, Alec W. Freyn, Sean T. H. Liu, Olivia Stovicek, et al. (+14)
12 [GO] 2021―May―03 COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters Guilherme Dias de Melo, Françoise Lazarini, Sylvain Levallois, Charlotte Hautefort, Vincent Michel, Florence Larrous, et al. (+15)
13 [GO] 2021―May―03 Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State Nicola F. Müller, Cassia Wagner, Chris D. Frazar, Pavitra Roychoudhury, Jover Lee, Louise H. Moncla, et al. (+37)
14 [GO] 2021―Apr―05 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates Bryan E. Jones, Patricia L. Brown-Augsburger, Kizzmekia S. Corbett, Kathryn Westendorf, Julian Davies, Thomas P. Cujec, et al. (+51)
15 [GO] 2021―Mar―15 T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals Tatjana Bilich, Annika Nelde, Jonas S. Heitmann, Yacine Maringer, Malte Roerden, Jens Bauer, et al. (+9)
16 [GO] 2021―Mar―15 SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 Juan A. Perez-Bermejo, Serah Kang, Sarah J. Rockwood, Camille R. Simoneau, David A. Joy, Ana C. Silva, et al. (+12)
17 [GO] 2021―Mar―10 Academic careers and the COVID-19 pandemic: Reversing the tide Rotonya M. Carr, Meghan B. Lane-Fall, Eugenia South, Donita Brady, Florence Momplaisir, Carmen E. Guerra, et al. (+4)
18 [GO] 2021―Feb―22 Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests Netta Barak, Roni Ben-Ami, Tal Sido, Amir Perri, Aviad Shtoyer, Mila Rivkin, et al. (+11)
19 [GO] 2021―Feb―03 Development and deployment of COVID-19 vaccines for those most vulnerable Wayne C. Koff, Theodore Schenkelberg, Tere Williams, Ralph S. Baric, Adrian McDermott, Cheryl M. Cameron, et al. (+13)
20 [GO] 2021―Jan―20 Could COVID-19 eliminate the alarm clock? Jennifer M. Hurley
21 [GO] 2021―Jan―11 Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys Emily Speranza, Brandi N. Williamson, Friederike Feldmann, Gail L. Sturdevant, Lizzette Pérez Pérez, Kimberly Meade-White, et al. (+9)
22 [GO] 2021―Jan―04 Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in COVID-19 patients and healthy individuals Sang Il Kim, Jinsung Noh, Sujeong Kim, Younggeun Choi, Duck Kyun Yoo, Yonghee Lee, et al. (+13)
23 [GO] 2020―Dec―09 Convalescent plasma in COVID-19: Does use case matter? Girish N. Nadkarni
24 [GO] 2020―Dec―08 IgA dominates the early neutralizing antibody response to SARS-CoV-2 Delphine Sterlin, Alexis Mathian, Makoto Miyara, Audrey Mohr, François Anna, Laetitia Claër, et al. (+21)
25 [GO] 2020―Dec―08 Enhanced SARS-CoV-2 neutralization by dimeric IgA Zijun Wang, Julio C. C. Lorenzi, Frauke Muecksch, Shlomo Finkin, Charlotte Viant, Christian Gaebler, et al. (+14)
26 [GO] 2020―Dec―01 Lung transplantation for patients with severe COVID-19 Ankit Bharat, Melissa Querrey, Nikolay S. Markov, Samuel Kim, Chitaru Kurihara, Rafael Garza-Castillon, et al. (+9)
27 [GO] 2020―Nov―24 Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 Alexandra Popa, Jakob-Wendelin Genger, Michael D. Nicholson, Thomas Penz, Daniela Schmid, Stephan W. Aberle, et al. (+32)
28 [GO] 2020―Nov―10 Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 Yu Zuo, Shanea K. Estes, Ramadan A. Ali, Alex A. Gandhi, Srilakshmi Yalavarthi, Hui Shi, et al. (+13)
29 [GO] 2020―Oct―19 Prospects for a safe COVID-19 vaccine Barton F. Haynes, Lawrence Corey, Prabhavathi Fernandes, Peter B. Gilbert, Peter J. Hotez, Srinivas Rao, et al. (+4)
30 [GO] 2020―Sep―21 Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients Carl A. Pierce, Paula Preston-Hurlburt, Yile Dai, Clare Burn Aschner, Natalia Cheshenko, Benjamin Galen, et al. (+13)
31 [GO] 2020―Aug―19 Considering COVID-19 kidney injury Girish N. Nadkarni
32 [GO] 2020―Aug―03 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice Athri D. Rathnayake, Jian Zheng, Yunjeong Kim, Krishani Dinali Perera, Samantha Mackin, David K Meyerholz, et al. (+6)
33 [GO] 2020―Jul―27 A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples Viet Loan Dao Thi, Konrad Herbst, Kathleen Boerner, Matthias Meurer, Lukas PM Kremer, Daniel Kirrmaier, et al. (+13)
34 [GO] 2020―Jul―20 An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates Jesse H. Erasmus, Amit P. Khandhar, Megan A. O’Connor, Alexandra C. Walls, Emily A. Hemann, Patience Murapa, et al. (+16)
35 [GO] 2020―Jul―01 Nanosponges intercept coronavirus infection Su Xinyi
36 [GO] 2020―Jun―22 Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States Justin D. Silverman, Nathaniel Hupert, Alex D. Washburne
37 [GO] 2020―Jun―10 The story of COVID-19: A comparative analysis Shaon Sengupta
38 [GO] 2020―Jun―08 Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits Supriya Ravichandran, Elizabeth M. Coyle, Laura Klenow, Juanjie Tang, Gabrielle Grubbs, Shufeng Liu, et al. (+3)
39 [GO] 2020―Jun―03 COVID-19 diagnostics in context Ralph Weissleder, Hakho Lee, Jina Ko, Mikael J. Pittet
40 [GO] 2020―May―27 Blood-borne biomarkers may help predict COVID-19 mortality Iwijn De Vlaminck
41 [GO] 2020―May―13 COVID-19 and cancer: The bad and the ugly Ecaterina Ileana-Dumbrava
42 [GO] 2020―Apr―29 An ACE therapy for COVID-19 Christopher B. Rodell
43 [GO] 2020―Apr―29 An ounce of public health for COVID-19? Girish N. Nadkarni
44 [GO] 2020―Apr―22 Can cell therapies halt cytokine storm in severe COVID-19 patients? James Ankrum
45 [GO] 2020―Apr―06 An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice Timothy P. Sheahan, Amy C. Sims, Shuntai Zhou, Rachel L. Graham, Andrea J. Pruijssers, Maria L. Agostini, et al. (+22)
46 [GO] 2020―Mar―11 New coronavirus outbreak: Framing questions for pandemic prevention Scott P. Layne, James M. Hyman, David M. Morens, Jeffery K. Taubenberger


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec